Project Grant K99AG084926
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$119K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $816,661 to The Regents of the University of California, San Francisco to conduct research aimed at elucidating the molecular and cellular mechanisms by which pathological tau protein drives neurodegeneration in Alzheimer's disease (AD) and related tauopathies. The research leverages expertise in mass spectrometry-based proteomics and functional genomics to comprehensively map the impact of tau...
The National Institute on Aging (NIA) awarded a $7,249,563 Project Grant under the Aging Research federal grant program (CFDA 93.866) to the Regents of the University of California, San Francisco (UCSF). This 3-year award, starting on Aug 1, 2023, will support research to characterize the structural properties and variability of tau protein aggregation in different brain cell types and at different disease stages of Alzheimer's and related dementias (ADRD). The project aims to develop new...
The National Institute on Aging (NIA) awarded a $4,276,054 Project Grant under the Aging Research (CFDA 93.866) federal grant program to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The grant supports the mathematical modeling and quantitative testing of hypotheses regarding the selective vulnerability of certain brain regions, cell types, and networks in mouse models of tauopathy, which is relevant to understanding the pathological progression of...
The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $437,250 project grant to the University of California, San Diego (UCSD). The grant, which runs from May 15, 2025 to April 30, 2027, will fund the development of new tools to image tau protein form and function in living cells. The project aims to create a peptide-based probe that uses aggregation-induced emission (AIE) to directly measure tau as it transitions from a soluble state to...
This $519,750 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a 2-year research study by the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco. The study aims to explore the underlying molecular mechanisms by which reducing levels of the tau protein can prevent or diminish excitation/inhibition imbalance and network hyperexcitability in the brain. This imbalance has been observed in various...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research (CFDA 93.866) federal grant program, supports research to understand the role of the tau protein in Alzheimer's disease and related dementias. The $1,592,854 award, effective from June 1, 2025 to May 31, 2027, will enable researchers at the University of Illinois to investigate how post-translational modifications and disease-related mutations in tau affect its function as a signaling scaffold and...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research (CFDA 93.866) federal grant program, will provide $717,709 to Weill Medical College of Cornell University from June 1, 2025 to March 31, 2030 to conduct research on the underlying mechanisms of tau protein aggregation and propagation in Alzheimer's disease and frontotemporal dementia. The key goals are to discover cellular pathways and protein interactions relevant to tau pathology using advanced...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) in the amount of $553,998.00 will fund research at the University of Notre Dame to develop a macrocyclic peptide platform for discovering functional tau epitopes related to neurodegenerative diseases like Alzheimer's. Key objectives include designing and screening a library of conformationally constrained peptide macrocycles that mimic pathological tau folds, validating their ability to seed endogenous...
This Project Grant award, with a total funding amount of $431,750, was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The award is for the development and evaluation of a novel immuno-gene therapy approach using a single-chain fragment variable (scFv) derived from an anti-tau oligomeric complex 1 (TOC1) antibody. The key objectives are to: 1) generate and validate the TOC1-scFv-HaloTag-Proteasome Degradation Signal (PDS)...
This federal Project Grant award for $372,690, provided by the National Institute on Aging (NIA) under the Aging Research (CFDA 93.866) program, is focused on discovering the heterogeneous causal pathophysiology of Alzheimer's disease (AD). The primary goals are to: (1) develop new statistical methods for uncovering heterogeneous causal relationships between amyloid-beta, tau accumulation, and cognition across diverse AD patient subpopulations; (2) apply these novel methods to existing AD...